Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | MGAM | O43451 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | SI | P14410 | 1/20 | 0.40 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.40 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | METAP2 | P50579 | 4/20 | 0.38 |
| ▸ | METAP1 | P53582 | 3/20 | 0.38 |
| ▸ | CAD | P27708 | 1/20 | 0.37 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6389387 | 1.00 | ALOX15 (0.46) | ALOX15SLC7A5ALDH1A1LMNAHSD17B10 | |
| SCHEMBL196141 | 1.00 | ALOX15 (0.46) | ALOX15SLC7A5ALDH1A1LMNAHSD17B10 | |
| Hydrochloric Acid SCHEMBL135321 | 0.98 | ALOX15 (0.44) | ALOX15SLC7A5ALDH1A1LMNAHSD17B10 | |
| SCHEMBL3918852 | 0.98 | ALOX15 (0.44) | ALOX15SLC7A5ALDH1A1LMNAHSD17B10 | |
| Hydrochloric Acid SCHEMBL6389383 | 0.98 | ALOX15 (0.44) | ALOX15SLC7A5ALDH1A1LMNAHSD17B10 | |
| SCHEMBL3918851 | 0.98 | ALOX15 (0.44) | ALOX15SLC7A5ALDH1A1LMNAHSD17B10 | |
| Hydrochloric Acid SCHEMBL138333 | 0.98 | ALOX15 (0.44) | ALOX15SLC7A5ALDH1A1LMNAHSD17B10 | |
| Hydrochloric Acid SCHEMBL20267442 | 0.95 | ALOX15 (0.42) | ALOX15SLC7A5ALDH1A1LMNAHSD17B10 | |
| Hydrochloric Acid SCHEMBL6846658 | 0.95 | ALOX15 (0.42) | ALOX15SLC7A5ALDH1A1LMNAHSD17B10 | |
| SCHEMBL8758723 | 0.89 | ALOX15 (0.38) | ALOX15SLC7A5ALDH1A1LMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 774 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122056386-A | Moisture absorption resistant slow release microcapsule powder and preparation method and application thereof | 大连医诺生物股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122030612-A | Shear-resistant slow-release microcapsule powder and preparation method and application thereof | 大连医诺生物股份有限公司 | 2026-05-15 | — | — | CN | claimed |
| EP-4673426-A1 | FUNCTIONALIZED BIODEGRADABLE SURFACTANTS AND METHODS USE | Locus Solutions IPCO, LLC (US) | 2026-01-07 | — | — | EP | claimed |
| US-20250346553-A1 | Process for the Preparation of R-Oxybutynin Hydrochloride | HARMAN FINOCHEM LTD (IN) | 2025-11-13 | — | — | US | claimed |
| CN-119470406-A | Phthalic dicarboxaldehyde disinfectant concentration detection test paper and preparation method thereof | 山东新华莎罗雅生物技术有限公司 | 2025-02-18 | — | — | CN | claimed |
| US-20240301322-A1 | FUNCTIONALIZED BIODEGRADABLE SURFACTANTS AND METHODS USE | LOCUS SOLUTIONS IPCO LLC (US) | 2024-09-12 | — | — | US | claimed |
| WO-2024182125-A1 | FUNCTIONALIZED BIODEGRADABLE SURFACTANTS AND METHODS USE | LOCUS SOLUTIONS IPCO, LLC (US) | 2024-09-06 | — | — | WO | claimed |
| WO-2024175614-A1 | STABLE LIQUID FORMULATIONS COMPRISING (6S)-5-METHYLTETRAHYDROFOLIC ACID OR SALTS THEREOF | MERCK PATENT GMBH (DE) | 2024-08-29 | — | — | WO | claimed |
| US-11992491-B2 | Crystalline salts of 5-methyl-(6S)-tetrahydrofolic acid and L-valine ethyl ester | MERCK PATENT GMBH (DE) | 2024-05-28 | — | — | US | claimed |
| EP-3817814-B1 | CRYSTALLINE SALTS OF 5-METHYL-(6S)-TETRAHYDROFOLIC ACID AND L-VALINE ETHYL ESTER | MERCK PATENT GMBH (DE) | 2023-09-20 | — | — | EP | claimed |
| US-20050137246-A1 | Organic amine salts of glutamic acid derivatives and their application | AJINOMOTO CO., INC. (JP) | 2005-06-23 | — | — | US | claimed |
| EP-1533300-A1 | Organic amine salts of glutamic acid derivatives and their application | Ajinomoto Co., Inc. (JP) | 2005-05-25 | — | — | EP | claimed |
| EP-1161480-B1 | BIODEGRADABLE AND THERMOSENSITIVE POLYPHOSPHAZENES AND THEIR PREPARATION METHOD | KOREA INST SCI & TECH (KR) | 2004-12-22 | — | — | EP | claimed |
| US-20040220264-A1 | Bioavailability and improved delivery of acidic pharmaceutical drugs | YU RUEY J | 2004-11-04 | — | — | US | claimed |
| WO-2004082628-A2 | IMPROVED BIOAVAILABILITY AND IMPROVED DELIVERY OF ACIDIC PHARMACEUTICAL DRUGS | YU RUEY J (US) | 2004-09-30 | — | — | WO | claimed |
| EP-1161480-A1 | BIODEGRADABLE AND THERMOSENSITIVE POLYPHOSPHAZENES AND THEIR PREPARATION METHOD | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2001-12-12 | — | — | EP | claimed |
| US-6319984-B1 | TEMPERATURE-SENSITIVITY AND BIODEGRADABILITY CAN BE CONTROLLED AS DESIRED BY SUBSTITUTING POLYDICHLOROPHOSPHAZENE WITH METHOXY HEPTA(ETHYLENE GLYCOL), DEPSIPEPTIDES AND AMINO ACID ESTERS | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2001-11-20 | — | — | US | claimed |
| WO-2001036516-A1 | BIODEGRADABLE AND THERMOSENSITIVE POLYPHOSPHAZENES AND THEIR PREPARATION METHOD | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2001-05-25 | — | — | WO | claimed |
| EP-0554422-B1 | USE OF DL-VALIN, ITS ESTERS AND/OR ITS SALTS IN THE TREATMENT OF DANDRUFF | WELLA AG (DE) | 1995-08-30 | — | — | EP | claimed |
| US-4940662-A | Low-molecular weight peptide mixture and method of producing same | TERUMO KABUSHIKI KAISHA (JP) | 1990-07-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250346553-A1 | Process for the Preparation of R-Oxybutynin Hydrochloride | GCG, GRHPR, CYP8B1 | ALOX15 416/4885SLC7A5 4113/4885ALDH1A1 2339/4885 |
| US-20050137246-A1 | Organic amine salts of glutamic acid derivatives and their application | MON2, SLC7A1, SLC7A5 | ALOX15 4624/4885SLC7A5 3/4885ALDH1A1 2846/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.